SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-22-078435
Filing Date
2022-03-17
Accepted
2022-03-17 17:11:09
Documents
4
Effectiveness Date
2022-03-17

Document Format Files

Seq Description Document Type Size
1 S-8 d335510ds8.htm S-8 29264
2 EX-5.1 d335510dex51.htm EX-5.1 4752
3 EX-23.1 d335510dex231.htm EX-23.1 2239
4 EX-FILING FEES d335510dexfilingfees.htm EX-FILING FEES 20493
  Complete submission text file 0001193125-22-078435.txt   57960
Mailing Address 131 HARTWELL AVENUE SUITE 320 LEXINGTON MA 02421
Business Address 131 HARTWELL AVENUE SUITE 320 LEXINGTON MA 02421 781-761-4904
Aldeyra Therapeutics, Inc. (Filer) CIK: 0001341235 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-263660 | Film No.: 22749793
SIC: 2834 Pharmaceutical Preparations